Quick Answer
NEOGEN CORP reported Cash and Equivalents of $129.00 million for fiscal year 2025.
NEOGEN CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $129.00M | -24.4% |
| 2024 | $170.61M | +4.5% |
| 2023 | $163.24M | +267.1% |
| 2022 | $44.47M | -41.2% |
| 2021 | $75.60M | +14.1% |
| 2020 | $66.27M | +59.0% |
| 2019 | $41.69M | -49.8% |
| 2018 | $83.07M | +7.1% |
| 2017 | $77.57M | +40.4% |
| 2016 | $55.26M | -16.4% |
| 2015 | $66.06M | +62.4% |
| 2014 | $40.67M | -18.7% |
| 2013 | $50.03M | +2.0% |
| 2012 | $49.05M | +36.8% |
| 2011 | $35.84M | +57.2% |
| 2010 | $22.81M | +64.8% |
| 2009 | $13.84M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $145.34M | +3.6% | +4.6% |
| August 31, 2025 | $138.88M | +15.3% | +7.7% |
| May 31, 2025 | $129.00M | -24.4% | +1.0% |
| February 28, 2025 | $127.70M | -20.9% | -8.9% |
| November 30, 2024 | $140.23M | -31.8% | +16.4% |
| August 31, 2024 | $120.48M | -32.6% | -29.4% |
| May 31, 2024 | $170.61M | +4.5% | +5.7% |
| February 29, 2024 | $161.44M | +140.5% | -21.5% |
- NEOGEN CORP showed a decrease of -24.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, NEOGEN CORP’s cash and equivalents has grown by 832.0% (from $13.84 million to $129.00 million).
- The most recent figure is from NEOGEN CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: